Hoffmann-La Roche Limited (Roche Canada) is pleased to announce today that VABYSMO® (faricimab injection) Pre-Filled Syringe (PFS) is now publicly funded though the Ontario Drug Benefit Program.1 ...

November, a month best known for Thanksgiving and harvest festivals, is also an important month for raising awareness about various health issues. Some of the key health ...

The introduction of five upcoming registrational readouts for 2026 is a new forward-looking highlight. Product net sales and operating profit both increased meaningfully quarter-over-quarter, as did ...

Regeneron has once again received a complete response letter (CRL) from the US Food and Drug Administration (FDA) for the ...